Product
Xuezhikang
1 clinical trial
3 indications
Indication
Metabolic DisorderIndication
LipidIndication
Blood sugarClinical trial
A 24-week, Multi-center, Randomized, Open-Label Clinical Trial to Compare the Impact of Xuezhikang and Atorvastatin on Glucose Metabolism in Dyslipidemia Patients With Prediabetes (XTREME Study)Status: Completed, Estimated PCD: 2024-04-02